American Century Companies’s Edgewise Therapeutics EWTX Stock Holding History

American Century Companies’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.8M	Sell	1,127,078 -20,098	-2%	-$693K	0.02%	893
2026 Q1	$36.1M	Sell	1,147,176 -39,291	-3%	-$1.13M	0.02%	912
2025 Q4	$29.4M	Buy	1,186,467 +90,994	+8%	+$1.83M	0.01%	971
2025 Q3	$17.8M	Buy	1,095,473 +312,307	+40%	+$4.43M	0.01%	1198
2025 Q2	$10.3M	Buy	783,166 +3,400	+0.4%	+$49K	0.01%	1363
2025 Q1	$17.2M	Buy	779,766 +9,413	+1%	+$247K	0.01%	1114
2024 Q4	$20.6M	Sell	770,353 -164,034	-18%	-$5.22M	0.01%	1027
2024 Q3	$24.9M	Buy	934,387 +74,320	+9%	+$1.48M	0.01%	927
2024 Q2	$15.5M	Buy	860,067 +300,733	+54%	+$5.25M	0.01%	1059
2024 Q1	$10.2M	Sell	559,334 -211,118	-27%	-$3.36M	0.01%	1199
2023 Q4	$8.43M	Buy	770,452 +242,613	+46%	+$1.7M	0.01%	1218
2023 Q3	$3.02M	Buy	527,839 +7,337	+1%	+$49.9K	﹤0.01%	1532
2023 Q2	$4.03M	Buy	520,502 +11,440	+2%	+$96.5K	﹤0.01%	1381
2023 Q1	$3.39M	Buy	509,062 +3,379	+0.7%	+$31.3K	﹤0.01%	1406
2022 Q4	$4.52M	Buy	505,683 +6,822	+1%	+$64K	﹤0.01%	1259
2022 Q3	$4.91M	Buy	498,861 +194,148	+64%	+$1.96M	﹤0.01%	1117
2022 Q2	$2.43M	Sell	304,713 -168	-0.1%	-$1.27K	﹤0.01%	1356
2022 Q1	$2.96M	Buy	304,881 +502	+0.2%	+$6.46K	﹤0.01%	1284
2021 Q4	$4.65M	Buy	304,379 +9,967	+3%	+$179K	﹤0.01%	1082
2021 Q3	$4.89M	Buy	294,412 +102	+0%	+$1.84K	﹤0.01%	1029
2021 Q2	$6.28M	Buy	294,310 +15,733	+6%	+$430K	﹤0.01%	938
2021 Q1	$9.05M	Buy	+278,577	New	+$9.03M	0.01%	801

Other funds holding EWTX

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JTL

Jupiter Topco LLC New York $245B AUM

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

American Century Companies's EWTX Position: Q2 2026 in Review

American Century Companies reduced its Edgewise Therapeutics (EWTX) stake by 1.8% in Q2 2026, selling an estimated $693K and leaving 1,127,078 shares worth $45.8M. The position accounts for 0.02% of the portfolio, ranked #893.

American Century Companies first reported a position in EWTX in Q1 2021 and has held it in 22 quarters since. 204 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

American Century Companies held 1,127,078 shares of Edgewise Therapeutics worth $45.8M as of Q2 2026.
American Century Companies sold 20,098 Edgewise Therapeutics shares in Q2 2026, an estimated $693K.
Edgewise Therapeutics made up 0.02% of American Century Companies's portfolio in Q2 2026, its #893 holding.
American Century Companies first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 22 quarters since.
204 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.